Leukemia
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 8.8 | Q1 | 91.3% | 3.675 | Q1 | 98.3% |
| 2024 | 13.4 | Q1 | 94.2% | 3.458 | Q1 | 98.2% |
| 2023 | 12.8 | Q1 | 93.3% | 3.662 | Q1 | 98.5% |
| 2022 | 11.4 | Q1 | 91.4% | 3.376 | Q1 | 98.4% |
| 2021 | 12.9 | Q1 | 92.0% | 4.030 | Q1 | 98.7% |
| 2020 | — | — | 4.539 | Q1 | 98.9% | |
| 2019 | — | — | 3.966 | Q1 | 98.7% | |
| 2018 | — | — | 4.518 | Q1 | 98.8% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1476-5551
ISSN
0887-6924
country
GBcoverage
1987-2026